ALDACTAZIDE is indicated for:
Edematous conditions for patients with:
*Congestive heart failure:
•
For the management of edema and sodium retention when the patient is only partially responsive to, or is intolerant of, other therapeutic measures;
•
The treatment of diuretic-induced hypokalemia in patients with congestive heart failure when other measures are considered inappropriate;
•
The treatment of patients with congestive heart failure taking digitalis when other therapies are considered inadequate or inappropriate.
*Cirrhosis of the liver accompanied by edema and/or ascites:
• Aldosterone levels may be exceptionally high in this condition. ALDACTAZIDE is indicated for maintenance therapy together with bed rest and the restriction of fluid and sodium.
The nephrotic syndrome:
• For nephrotic patients when treatment of the underlying disease, restriction of fluid and sodium intake, and the use of other diuretics do not provide an adequate response.
*Essential hypertension:
•
For patients with essential hypertension in whom other measures are considered inadequate or inappropriate;
•
In hypertensive patients for the treatment of a diuretic-inducedhypokalemia when other measures are considered inappropriate;
•
ALDACTAZIDE is indicated for the treatment of hypertension, to lower blood pressure.
